$0.299900
0.00592.01%
Last update: 12:58 PM
15 minutes delayed
Ensysce Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ensysce Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.22 | $-0.39 | 43.6 % |
Mar 2024 | 2024-05-13 | $-0.55 | $-0.93 | 40.9 % |
Dec 2023 | 2024-03-15 | $-1.13 | $-0.87 | -29.9 % |
Sep 2023 | 2023-11-09 | $-0.87 | $-1.06 | 17.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $181.80K | $300.00K | -39.4 % |
Mar 2024 | 2024-05-13 | $305.72K | $400.00K | -23.6 % |
Dec 2023 | 2024-03-15 | $515.03K | $390.00K | 32.1 % |
Sep 2023 | 2023-11-09 | $435.38K | $590.00K | -26.2 % |
Ensysce Biosciences (ENSC) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.22, which beat the estimate of $-0.39.
The Actual Revenue was $181.8K, which missed the estimate of $300K.
Browse earnings estimates, EPS, and revenue on all stocks.